This document is intended to outline some of the potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.
Based on insights from a related workshop series, this document outlines potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.
For National Minority Cancer Awareness Month, AdvaMed’s DeChane Dorsey reflects on the continued need for improvements in health equity and the impact of cancer on racial and ethnic minority groups.
AdvaMed submitted a response to a White House Office of Science and Technology Policy (OSTP) Request for Information (RFI) on Strengthening Community Health Through Technology.
AdvaMed is pleased to be a founding collaborator in a partnership with the American Medical Association and other health care industry leaders to address health inequities through innovation.
Mike Mussallem, Chairman and CEO of Edwards Lifesciences, joined AdvaMed’s Scott Whitaker on the Medtech POV podcast to talk about policy opportunities that could improve the process of getting life-saving medical technologies…
Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, at Johnson & Johnson (J&J) recently joined AdvaMed’s Scott Whitaker on the Medtech POV podcast where they discussed how she is reimagining the future…
Olympus Corporation Chief Operating Officer Nacho Abia recently joined AdvaMed’s Scott Whitaker on the Medtech POV podcast.
We are committed to ensuring that our mission is not compromised by the perpetuation of racial health disparities.
Unequal access to medical technologies and, more broadly, health care services continues to persist – often disproportionately impacting the lives of racial and ethnic minorities.